Optipharm.CO.,LTD (KOSDAQ: A153710)
Health Care · Biotechnology · KR
₩4,565.00
-5.19% today · -14.0% 1Y
Optipharm.CO.,LTD (KOSDAQ: A153710) operates in the Biotechnology industry within the Health Care sector. The company is valued at $48.32M.
Over the last twelve months the share price has lost 14.0%, trading between 4.08K and 6.25K.
Tweenvest scores Optipharm.CO.,LTD across four factors: quality 51/100, value 77/100, growth 58/100. Its strongest factor is value.
A153710 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.32M
- Revenue (TTM)
- $14.97M
- P/E
- —
- EPS
- -143.97
- Dividend yield
- —
- Beta (5Y)
- 0.10
- 52-week high
- ₩6,250.00
- 52-week low
- ₩4,075.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.67M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $266.29 | +0.67% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $445.02 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.42 | +1.14% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $555.26 | +1.40% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $837.90 | +1.13% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $157.60 | +13.47% |
Figures last refreshed Aug 18, 2026.